Versuchen GOLD - Frei
'PPPs, CoEs Are Needed To Practice Precision Diabetes Care'
Bio Spectrum
|November 2019
Roche Diabetes Care India, a pioneer in the development of diabetes management systems and services, has appointed executive from Novo Nordisk, Omar Sherief Mohammad as the new General Manager for its India business.
He assumed his new role with effect from September 23, 2019, and is also serving as a member of the Roche Diabetes Care Asia Pacific Leadership Team. Soon after his appointment, BioSpectrum interacted with him, to find out more about his plans for the company towards addressing the burden of diabetes. Edited Excerpts;
What new strategy is in store for driving the development of integrated diabetes management solutions?
Our philosophy revolves around the patient. We have a 1000 days ambition to 100 years of the discovery of insulin. Diabetes: India and Diabetes are synonymous and the biggest issue is that there are 73 million people with diabetes in the country and only 50 percent of them are diagnosed. Out of these only, 50 percent have access to treatment. Therefore, the number of cases treated is less than 10 percent. Thus we will focus on breaking the rule of halves in diabetes by ensuring we are able to not only diagnose diabetes earlier but also bring access to care for people with diabetes for which we will invest in partnerships to answer the question of how to solve the bigger problem which is at the patient level. We believe, if we control the problem for the patient and the peer and the caregiver, which is the healthcare professional, we will be able to bend the curve of diabetes.
What kind of partnerships or collaborations are you seeking, as part of your strategy?
Diese Geschichte stammt aus der November 2019-Ausgabe von Bio Spectrum.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Bio Spectrum
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 mins
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 mins
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 mins
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 mins
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 mins
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min
March 2026
Bio Spectrum
Centre revises Startup Recognition Framework to strengthen Startup India Action Plan
The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.
1 min
March 2026
Bio Spectrum
"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"
In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.
5 mins
March 2026
Translate
Change font size

